IRAKIMID

Serial Number 88754002
606

Registration Progress

Application Filed
Jan 10, 2020
Under Examination
Jun 30, 2020
Approved for Publication
May 5, 2020
Published for Opposition
May 5, 2020
Registered

Trademark Image

IRAKIMID

Basic Information

Serial Number
88754002
Filing Date
January 10, 2020
Published for Opposition
May 5, 2020
Abandonment Date
July 31, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 31, 2023
Classes
005

Rights Holder

Kymera Therapeutics, Inc.

03
Address
200 Arsenal Yards Blvd., Suite 230
Watertown, MA 02472

Ownership History

Kymera Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Kymera Therapeutics, Inc.

Owner at Publication
03
Watertown, MA

Legal Representation

Attorney
Glenn A. Gundersen

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Jul 31, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 31, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 6, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 5, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 29, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 29, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 30, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 28, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 28, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 28, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 29, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 27, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 27, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 27, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 2, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 30, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 30, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 30, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 17, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 16, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 25, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 10, 2021 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Feb 9, 2021 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Feb 9, 2021 PETG O PETITION TO REVIVE-GRANTED Loading...
Feb 9, 2021 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Feb 1, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 1, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 30, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 30, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 5, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 5, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 15, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 30, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 30, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 15, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 14, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005